Vodafone 1H EBITDA Down 4.1%

Nov. 12 (Bloomberg) –- Bloomberg’s Manus Cranny reports Vodafone earnings and the company’s investment plan. He speaks to Mark Barton and Anna Edwards on Bloomberg Television’s “Countdown.” (Source: Bloomberg)
Pfizer, Merck 2Q Profits Beat Estimates
34:57 - Pfizer reported second-quarter earnings that beat analysts’ estimates and raised its full-year profit forecast as sales of a new cancer drug climbed. Bloomberg's Cynthia Koons also reports on Merck's performance on "Market Makers." (Source: Bloomberg)
  • U.K. Construction Industry 'Doing Pretty Well': Lamont
  • What You Need to Know for Tuesday's Market
  • Why You Don't Want to Bet Against the Bull Market